IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)

Plain-language summary

This study examines how BRCA gene mutation status affects survival in early-stage breast cancer. Patients over 18 with histologically confirmed early invasive breast cancer who received neoadjuvant and/or adjuvant chemotherapy were included. It was carried out as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Centre Hospitalier Universitaire de Besancon

Intervention

BRCA mutation

Start date

7/28/2017

Estimated completion

6/21/2018

Countries

France

Related genes

Locations

• Besançon, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients older than 18 years old,
* Histologically confirmed invasive early breast cancer
* Neo-adjuvant and/or adjuvant chemotherapy with the first cure of chemotherapy received between January 1st, 2003 and December 31th, 2013

Exclusion Criteria:

* Clinical, radiological or histological confirmed metastatic disease
* Non-invasive breast cancer,
* Patients who received incomplete treatment
* Patients who did not speak French